Taiwan · Delayed Price · Currency is TWD Sinphar Pharmaceutical Statistics
Total Valuation
TPE:1734 has a market cap or net worth of TWD 6.07 billion. The enterprise value is 6.78 billion.
| Market Cap | 6.07B |
| Enterprise Value | 6.78B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
TPE:1734 has 190.20 million shares outstanding. The number of shares has decreased by -0.14% in one year.
| Current Share Class | 190.20M |
| Shares Outstanding | 190.20M |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.92% |
| Owned by Insiders (%) | 9.81% |
| Owned by Institutions (%) | 2.83% |
| Float | 133.25M |
Valuation Ratios
The trailing PE ratio is 18.54.
| PE Ratio | 18.54 |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | 16.32 |
| P/OCF Ratio | 9.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.60, with an EV/FCF ratio of 18.24.
| EV / Earnings | 20.74 |
| EV / Sales | 2.00 |
| EV / EBITDA | 10.60 |
| EV / EBIT | 16.99 |
| EV / FCF | 18.24 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.37 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 2.58 |
| Debt / FCF | 4.45 |
| Interest Coverage | 12.46 |
Financial Efficiency
Return on equity (ROE) is 8.38% and return on invested capital (ROIC) is 7.77%.
| Return on Equity (ROE) | 8.38% |
| Return on Assets (ROA) | 3.92% |
| Return on Invested Capital (ROIC) | 7.77% |
| Return on Capital Employed (ROCE) | 7.59% |
| Weighted Average Cost of Capital (WACC) | 4.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, TPE:1734 has paid 66.44 million in taxes.
| Income Tax | 66.44M |
| Effective Tax Rate | 17.49% |
Stock Price Statistics
The stock price has increased by +2.90% in the last 52 weeks. The beta is 0.12, so TPE:1734's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +2.90% |
| 50-Day Moving Average | 31.28 |
| 200-Day Moving Average | 31.01 |
| Relative Strength Index (RSI) | 64.54 |
| Average Volume (20 Days) | 406,900 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1734 had revenue of TWD 3.39 billion and earned 327.17 million in profits. Earnings per share was 1.72.
| Revenue | 3.39B |
| Gross Profit | 1.48B |
| Operating Income | 399.35M |
| Pretax Income | 379.94M |
| Net Income | 327.17M |
| EBITDA | 639.45M |
| EBIT | 399.35M |
| Earnings Per Share (EPS) | 1.72 |
Balance Sheet
The company has 1.21 billion in cash and 1.65 billion in debt, with a net cash position of -446.06 million or -2.35 per share.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 1.65B |
| Net Cash | -446.06M |
| Net Cash Per Share | -2.35 |
| Equity (Book Value) | 3.81B |
| Book Value Per Share | 18.69 |
| Working Capital | 1.59B |
Cash Flow
In the last 12 months, operating cash flow was 637.12 million and capital expenditures -265.24 million, giving a free cash flow of 371.88 million.
| Operating Cash Flow | 637.12M |
| Capital Expenditures | -265.24M |
| Depreciation & Amortization | 240.10M |
| Net Borrowing | -113.34M |
| Free Cash Flow | 371.88M |
| FCF Per Share | 1.96 |
Margins
Gross margin is 43.52%, with operating and profit margins of 11.77% and 9.64%.
| Gross Margin | 43.52% |
| Operating Margin | 11.77% |
| Pretax Margin | 11.20% |
| Profit Margin | 9.64% |
| EBITDA Margin | 18.85% |
| EBIT Margin | 11.77% |
| FCF Margin | 10.96% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.13%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 3.13% |
| Dividend Growth (YoY) | 5.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 55.37% |
| Buyback Yield | 0.14% |
| Shareholder Yield | 3.28% |
| Earnings Yield | 5.39% |
| FCF Yield | 6.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 2, 2025. It was a forward split with a ratio of 1.05.
| Last Split Date | Sep 2, 2025 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |